调节鞘脂代谢可减轻心肌梗死后细胞死亡和炎症反应
研究探讨了酸性神经酰胺酶(AC)过表达对心肌梗死(MI)后心脏保护的作用。通过转录组、鞘脂和蛋白分析,发现MI后24小时神经酰胺水平显著升高,AC抑制增加细胞死亡,而AC modRNA治疗改善心功能、延长生存并减小瘢痕。结论提示AC modRNA在缺血性心脏病中具有治疗潜力。
要点
- MI后24小时神经酰胺(C16、C20、C20:1、C24)水平显著升高。
- AC抑制减少AC活性并增加细胞死亡,AC modRNA增强AC活性促进细胞存活。
- AC modRNA治疗改善MI后28天心功能、生存和瘢痕大小。
核心结论
- 通过AC过表达短暂调节鞘脂代谢足以且必要地诱导MI后心脏保护。
研究设计与样本
- 研究进行转录组、鞘脂和蛋白分析评估MI后鞘脂代谢和信号。
- 通过化学抑制剂(功能缺失)或修饰mRNA(功能获得)改变AC功能,在缺氧或MI后观察效果。
主要发现
- MI后24小时参与从头合成神经酰胺的多个基因上调,神经酰胺(C16、C20、C20:1、C24)水平显著升高。
- 缺氧或MI后AC抑制导致AC活性降低和细胞死亡增加。
- AC modRNA治疗增加缺氧或MI后的细胞存活。
- AC modRNA治疗小鼠MI后28天心功能显著更好、生存更长、瘢痕更小。
- 心功能改善归因于神经酰胺水平降低、细胞死亡率降低和左心室免疫细胞组成变化(促炎中性粒细胞丰度降低)。
临床怎么用
- AC modRNA可能作为缺血性心脏病的治疗策略,但需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sphingolipids have recently emerged as a biomarker of recurrence and mortality after myocardial infarction (MI). The increased ceramide levels in mammalian heart tissues during acute MI, as demonstrated by several groups, is associated with higher cell death rates in the left ventricle and deteriorated cardiac function. Ceramidase, the only enzyme known to hydrolyze proapoptotic ceramide, generates sphingosine, which is then phosphorylated by sphingosine kinase to produce the prosurvival molecule sphingosine-1-phosphate. We hypothesized that Acid Ceramidase (AC) overexpression would counteract the negative effects of elevated ceramide and promote cell survival, thereby providing cardioprotection after MI. METHODS: We performed transcriptomic, sphingolipid, and protein analyses to evaluate sphingolipid metabolism and signaling post-MI. We investigated the effect of altering ceramide metabolism through a loss (chemical inhibitors) or gain (modified mRNA [modRNA]) of AC function post hypoxia or MI. RESULTS: We found that several genes involved in de novo ceramide synthesis were upregulated and that ceramide (C16, C20, C20:1, and C24) levels had significantly increased 24 hours after MI. AC inhibition after hypoxia or MI resulted in reduced AC activity and increased cell death. By contrast, enhancing AC activity via AC modRNA treatment increased cell survival after hypoxia or MI. AC modRNA-treated mice had significantly better heart function, longer survival, and smaller scar size than control mice 28 days post-MI. We attributed the improvement in heart function post-MI after AC modRNA delivery to decreased ceramide levels, lower cell death rates, and changes in the composition of the immune cell population in the left ventricle manifested by lowered abundance of proinflammatory detrimental neutrophils. CONCLUSIONS: Our findings suggest that transiently altering sphingolipid metabolism through AC overexpression is sufficient and necessary to induce cardioprotection post-MI, thereby highlighting the therapeutic potential of AC modRNA in ischemic heart disease.
引用
- Hadas Y, Vincek AS, Youssef E, et al. Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction. Circulation. 2020. PMID: 31992066. doi:10.1161/CIRCULATIONAHA.119.041882
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。